ALK7 Signaling Manifests a Homeostatic Tissue Barrier That Is Abrogated during Tumorigenesis and Metastasis

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Tumorigenesis and metastasis are complex processes involving multiple signaling pathways.
• The TGFß superfamily plays a critical role in regulating cell growth, differentiation, and apoptosis.
• Understanding the specific roles of receptors like ALK7 in cancer is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the role of the TGFß superfamily receptor ALK7 in suppressing tumorigenesis and metastasis.
• To elucidate the mechanisms by which ALK7 signaling influences cancer cell apoptosis and evasion strategies.
• To correlate ALK7 expression with patient survival outcomes in various human cancers.

Main Methods:

• Functional studies in mouse models of pancreatic neuroendocrine and luminal breast cancer.
• Experimental metastasis assays to assess metastatic potential.
• Analysis of ALK7 and activin B expression in cancer cells and patient samples.

Main Results:

• ALK7 acts as a suppressor of tumorigenesis and metastasis in preclinical models.
• Activation of ALK7 signaling by activin B induces apoptosis in neoplastic cells.
• Cancer cells evade ALK7-mediated apoptosis by downregulating activin B and/or ALK7.
• Suppression of ALK7 expression enhances metastatic seeding.
• ALK7 expression correlates with shorter relapse-free and distant-metastasis-free survival in cancer patients.

Conclusions:

• ALK7 functions as a critical tumor suppressor by establishing a protective barrier that induces apoptosis in unauthorized proliferating cells.
• Downregulation of the ALK7/activin B pathway is a key mechanism for cancer cells to evade apoptosis and promote tumor progression and metastasis.
• ALK7 represents a potential therapeutic target for improving cancer patient survival.